Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Q2 2025 Earnings Call Transcript
Operator: Good day, ladies and gentlemen, and thank you for standing by. Welcome to the Nautilus Biotechnology Second Quarter 2025 Earnings Conference Call.
Nautilus Biotechnology Inc. (NAUT)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Perceptive Advisors Joseph Edelman | 12,594,211 | $9,130,802 | 0.34% | |
| 2. | Cercano Management Chris Orndorff | 7,172,985 | $5,199,697 | 0.15% | |
| 3. | Millennium Management Israel Englander | 1,056,839 | $766,103 | +1080% | 0% |
| 4. | Renaissance Technologies Jim Simons | 619,906 | $449,370 | +107% | 0% |
| 5. | Alyeska Investment Group Anand Parekh | 253,468 | $183,739 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.68 | 83,500 | $57,030.50 | 10,341,721 | 2025-09-08 | Filing | |
| $0.67 | 116,500 | $78,544.30 | 10,258,221 | 2025-09-05 | Filing | |
| $0.64 | 20,000 | $12,858.00 | 74,140 | 2025-09-04 | Filing | |
| $0.77 | 15,000 | $11,488.50 | 83,000 | 2025-05-29 | Filing | |
| $0.73 | 1,500 | $1,097.55 | 20,493,392 | 2025-05-12 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.87 | 47,031 | $134,743.82 | 0 | 2024-09-23 | Filing | |
| $2.85 | 35,000 | $99,869.00 | 0 | 2024-09-17 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,209,646 | $1,021,862 | 0.06% | |
| 2. | 17 | $15 | 0% | |
| 3. | 182 | $0 | 0% |
News See All
Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Q1 2025 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Nautilus First Quarter 2025 Earnings Conference Call. At this time, all participants are in listen-only mode.
Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Q4 2024 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Nautilus Fourth Quarter and Full Year 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Q3 2024 Earnings Call Transcript
Operator: Good day everyone, and thank you for standing by and welcome to Nautilus Third Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Q2 2024 Earnings Call Transcript
Operator: Good day and thank you for standing by and welcome to Nautilus Q2 2024 Earnings Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded.
Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Q1 2024 Earnings Call Transcript
Nautilus Biotechnology, Inc. beats earnings expectations. Reported EPS is $-0.00015, expectations were $-0.16.
Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Q4 2023 Earnings Call Transcript
Nautilus Biotechnology, Inc. beats earnings expectations. Reported EPS is $0.14, expectations were $-0.16.
Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Q3 2023 Earnings Call Transcript
Operator: Thank you for standing by, and welcome to the Nautilus Third Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Q2 2023 Earnings Call Transcript
Operator: Thank you for standing by, and welcome to the Nautilus Biotechnology Second Quarter 2023 Earnings Conference Call. [Operator Instructions] As a reminder, today's program is being recorded.
Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Q1 2023 Earnings Call Transcript
Operator: Good morning and thank you for standing by. Welcome to the Nautilus First Quarter 2023 Earnings Conference Call.
Hedge Fund Resource Center Billionaire Hedge Funds
